AlphAIalphai — Financial news for AI agents
finance.yahoo.comJUN 24 min read$MDB

MongoDB (MDB) Soars 20.4% as UBS Raises PT by Double-Digits

MongoDB shares rose 20.36% to close at $403.88 on Monday, extending a three-day winning streak. UBS raised its price target 27% to $350 from $275 while keeping a neutral rating. UBS cited MongoDB’s Q1 FY2027 shift to profit of $4.4M and revenue up 25% to $687.6M; MongoDB guided Q2 revenue to $729M–$734M.

Original reporting
finance.yahoo.com
Published Jun 2, 2026, 4:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 5:18 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
MongoDB (MDB) Soars 20.4% as UBS Raises PT by Double-Digits — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$MDBBullishMed
01

Why it matters

The combination of a profit swing, 25% YoY revenue growth, and raised Q2 revenue outlook can extend momentum, but the neutral rating implies investors may need additional upside evidence for further rerating.

02

Market read

This is a single-name catalyst: an analyst PT raise layered on top of reported earnings and forward revenue guidance, aligning with the observed sharp price move.

03

What to watch

Follow-through depends on whether Q2 revenue guidance (implied 23–24% growth) is enough to shift UBS from neutral to positive, and whether subscription/service mix sustains.

Relevance 9/10Novelty 6/10Timing: after-hours/early session reaction to UBS PT upgrade and latest Q1/Q2 guidance

Background

MongoDB reported Q1 FY27 results (profit turnaround and revenue growth) and is now seeing analyst PT support after the print.

Company-level read

Ticker impact

$MDBBullishMedium confidence
Context

MongoDB shares surged after UBS raised its price target by 27% following the company’s Q1 FY27 profit and revenue growth.

Expected impact

Bullish bias for follow-through, but upside may be capped by the neutral rating and the PT still below the recent close.

Evidence & confidence

The article cites a concrete analyst PT upgrade and includes reported Q1 datapoints and Q2 revenue guidance; however, UBS maintained a neutral stance and the PT is below the latest close, limiting conviction.

Market effects

Sector

Reinforces positive sentiment toward database/data-platform software names tied to subscription growth and AI-adjacent enterprise demand.

Regional

Primarily US tech/enterprise software sentiment; no specific regional linkage cited.

Global

Limited—no global macro or cross-border deal/regulatory catalyst mentioned.

Counterpoint

What could challenge this read

The stock’s move may already price in the UBS upgrade; UBS’s neutral stance and PT below the latest close suggest risk of mean reversion.

Key entities

  • company
    MongoDB Inc.

    Subject of the article; shares jumped ~20% and UBS raised its PT after Q1 FY27 results and Q2 guidance.

  • analyst_firm
    UBS

    Raised MongoDB’s price target to $350 from $275 while keeping a neutral stance.

Read at source← All news

Related articles

JUN 5
$MDBMedAI 9/10

MongoDB Is the Latest SaaS Apocalypse Victim to Say Not Today

MongoDB shares rose nearly 40% from pre-earnings levels after the company’s blowout earnings report last week, which the article says beat expectations across key metrics and reduced concerns that AI would hurt growth. It also notes analysts raised price targets afterward, with some projecting about 20% additional upside from current levels.

finance.yahoo.com6 min
JUN 1
$MDBMedAI 9/10

MongoDB (MDB) Stock Trades Up, Here Is Why

MongoDB shares rose 17.9% in the afternoon after its May 28 earnings beat and a broader software-sector rotation, according to the article. For Q1 FY2027, revenue was $687.6M (+25% YoY) vs. $664.5M expected; adjusted EPS was $1.32 vs. $1.19. Atlas revenue grew 29.4% to $512.5M; free cash flow was $197.5M. Guidance was raised to $2.92–$2.96B revenue and $5.95–$6.14 EPS.

markets.financialcontent.com4 min
MAY 31
$SNOWMedAI 9/10

Software Was the Market's Big Laggard This Year. Snowflake's Blowout Might Be the Spark That Changes That.

Software stocks lagged early 2026 despite gains in the S&P 500, and Snowflake shares fell more than 50% from a year earlier in April. After fiscal Q1 ended April 30, Snowflake reported product revenue up 34% to $1.33B, non-GAAP operating margin rising to 12%, and EPS of $0.39. Management lifted full-year product revenue guidance to $5.84B and said AI is increasing data/workload consumption; Datadog and MongoDB also reported accelerating results.

fool.com6 min
MAY 30
$MDBMedAI 8/10

Cantor Fitzgerald Raises MongoDB (MDB) Price Target on Stable Outlook and AI Demand

Cantor Fitzgerald analyst Thomas Blakey raised MongoDB’s (MDB) price target to $416 from $378 and kept an Overweight rating, citing channel checks showing last quarter’s results were broadly in line and a stable forward outlook supported by AI demand. Separately, BMO Capital analyst Keith Bachman lifted his target to $360 from $285 with an Outperform rating, saying MongoDB is well positioned for durable long-term growth in AI workloads.

finance.yahoo.com3 min